Impact of hospitalised patients with COVID-19 taking Renin-Angiotensin-Aldosterone System inhibitors: a systematic review and meta-analysis
View ORCID ProfileRanu Baral, Maddie White, View ORCID ProfileVassilios S Vassiliou
doi: https://doi.org/10.1101/2020.05.03.20089375
Ranu Baral
aNorfolk and Norwich University Hospital, Norwich, United Kingdom
Maddie White
bNorwich Medical School, University of East Anglia, Norwich, United Kingdom
Vassilios S Vassiliou
aNorfolk and Norwich University Hospital, Norwich, United Kingdom
bNorwich Medical School, University of East Anglia, Norwich, United Kingdom
Article usage
Posted May 08, 2020.
Impact of hospitalised patients with COVID-19 taking Renin-Angiotensin-Aldosterone System inhibitors: a systematic review and meta-analysis
Ranu Baral, Maddie White, Vassilios S Vassiliou
medRxiv 2020.05.03.20089375; doi: https://doi.org/10.1101/2020.05.03.20089375
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (625)
- Anesthesia (162)
- Cardiovascular Medicine (2349)
- Dermatology (206)
- Emergency Medicine (377)
- Epidemiology (11728)
- Forensic Medicine (10)
- Gastroenterology (697)
- Genetic and Genomic Medicine (3705)
- Geriatric Medicine (347)
- Health Economics (632)
- Health Informatics (2380)
- Health Policy (928)
- Hematology (340)
- HIV/AIDS (773)
- Medical Education (364)
- Medical Ethics (104)
- Nephrology (396)
- Neurology (3467)
- Nursing (197)
- Nutrition (520)
- Oncology (1805)
- Ophthalmology (534)
- Orthopedics (218)
- Otolaryngology (286)
- Pain Medicine (231)
- Palliative Medicine (66)
- Pathology (445)
- Pediatrics (1025)
- Primary Care Research (417)
- Public and Global Health (6111)
- Radiology and Imaging (1266)
- Respiratory Medicine (822)
- Rheumatology (376)
- Sports Medicine (320)
- Surgery (397)
- Toxicology (50)
- Transplantation (171)
- Urology (145)